share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰制药 | 144:拟议出售证券
美股SEC公告 ·  08/30 16:28
Moomoo AI 已提取核心信息
Vertex Pharmaceuticals Director and Officer, JEFFREY LEIDEN, is set to sell 3,784 shares of the company's common stock on 08/30/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $1,866,836.40, were acquired on 02/07/2024 through a Restricted Stock Unit/Performance Stock Unit (RSU/PSU) transaction with the issuer. This planned sale follows a period where no other securities transactions were reported by LEIDEN in the past three months. The notice of the intended sale was filed on the same date as the planned sale, with the instruction for the sale having been given earlier on 05/10/2024.
Vertex Pharmaceuticals Director and Officer, JEFFREY LEIDEN, is set to sell 3,784 shares of the company's common stock on 08/30/2024, as announced in a recent filing. The shares, valued at an aggregate market value of $1,866,836.40, were acquired on 02/07/2024 through a Restricted Stock Unit/Performance Stock Unit (RSU/PSU) transaction with the issuer. This planned sale follows a period where no other securities transactions were reported by LEIDEN in the past three months. The notice of the intended sale was filed on the same date as the planned sale, with the instruction for the sale having been given earlier on 05/10/2024.
福泰制药董事兼高管 JEFFREY LEIDEN 计划于2024年08月30日卖出公司普通股票3,784股,根据最近的报告公告。这些股票的市值总计1866836.40美元,是在2024年02月07日通过受限制股票单位/绩效股票单位(RSU/PSU)交易与该发行人获得的。该计划销售是在过去三个月里,LEIDEN未报告其他证券交易的一段时间后进行的。有关拟售股份的通知是在同一天提交的,销售指令是在2024年05月10日之前给出的。
福泰制药董事兼高管 JEFFREY LEIDEN 计划于2024年08月30日卖出公司普通股票3,784股,根据最近的报告公告。这些股票的市值总计1866836.40美元,是在2024年02月07日通过受限制股票单位/绩效股票单位(RSU/PSU)交易与该发行人获得的。该计划销售是在过去三个月里,LEIDEN未报告其他证券交易的一段时间后进行的。有关拟售股份的通知是在同一天提交的,销售指令是在2024年05月10日之前给出的。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息